Login / Signup

The treatment of aggressive prolactinomas with everolimus.

Andrew L LinEliza B GeerNupur LalaGabrielle Page-WilsonRajiv MaggeRobert J YoungViviane Tabar
Published in: Pituitary (2023)
Everolimus is an active agent in the treatment of prolactinomas that warrants further investigation.
Keyphrases
  • combination therapy